- Source: Idursulfase
Idursulfase (brand name Elaprase), manufactured by Takeda, is a drug used to treat Hunter syndrome (also called MPS-II). It is a purified form of iduronate-2-sulfatase, a lysosomal enzyme, and is produced by recombinant DNA technology in a human cell line.
It is one of the most expensive drugs ever produced, costing US$567,412 per patient per year.
References
External links
idursulfase at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
Kata Kunci Pencarian:
- Idursulfase
- Hunter syndrome
- ATC code A16
- List of drugs: Ia–Il
- Enzyme replacement therapy
- Sanofi
- Iduronate-2-sulfatase
